SPPI New Lead Plaintiff Deadline: Contact Robbins LLP for Information About Leading the Class Action Against SPPI

SAN DIEGO, Aug. 26, 2025 /PRNewswire/ -- Robbins LLP reminds investors who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) common stock between March 17, 2022 and September 22, 2022, of the reopening of the Lead Plaintiff appointment process in the pending securities class action. Spectrum purports to be a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies.

Read more at prnewswire.com